Skip to content

Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D

Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06745778
Enrollment
50
Registered
2024-12-20
Start date
2025-02-26
Completion date
2026-07-31
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Fibrillation, Ventricular Tachycardia (VT)

Brief summary

The goal of this observational study is to investigate the changes of LBB EGM during daily activities and overdrive pacing at the time of peri-implantation and up to 6-month follow-ups of ICD/CRT-D patients. The main question it aims to answer is: • Does the LBBP lead can provide accurate, stable, and valid EGM for ICD/CRT-D sensing and detection of ventricular tachyarrhythmia events? In each patient intracardiac EGMs of LBBP lead will be collected by ambulatory Holter monitor at the time of peri-implantation and up to 6-month follow-up. EGM collection will be collected at resting and walking conditions and overdrive pacing.

Interventions

None listed

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged \>=18 yrs. * Patients indicated for ICD or CRT-D (primary or secondary prevention) * Patients who recently (\<=30 days) received ICD/CRT-D implantation with LBBP * Patients' EGM can be digitally recorded * Patients are willing to participate in the study and provide signed informed consent

Exclusion criteria

* Patients received CIED upgrade or replacement with old pacing leads * Patients are pregnant * Patients participate in another study that will confound this study

Design outcomes

Primary

MeasureTime frameDescription
R-wave amplitude of LBB EGMAt the enrollment, 3 months after enrollment and 6 months after enrollmentAmplitude in millivolt

Secondary

MeasureTime frameDescription
EGM morphology-LVATAt the enrollment, 3 months after enrollment and 6 months after enrollmentLVAT in millisecond, calculated based on electrogram recorded by LBB lead

Countries

China

Contacts

CONTACTSimon Cao, Ph.D
simon.cao@medtronic.com862133230325

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026